Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies
- PMID: 39364876
- DOI: 10.14309/ajg.0000000000003111
Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies
Abstract
Introduction: Gallstone diseases affect intestinal inflammation, bile flow, and gut microbiota, which in turn may increase the risk of inflammatory bowel disease (IBD). However, epidemiological studies exploring the associations between gallstone diseases and subsequent IBD risk have been limited.
Methods: This is a combined analysis of 3 prospective cohort studies (Nurses' Health Study, Nurses' Health Study II, and UK Biobank) and replicated in a case-control study (Chinese IBD Etiology Study). We evaluated the hazard ratios (HRs)/odds ratios (ORs) between gallstone diseases with IBD risk by Cox logistic regression or conditional logistic regression, adjusting for demographic characteristics, lifestyles, comorbidities, and medication usage.
Results: We identified 3,480 cases of IBD over 2,127,471 person-years of follow-up in the 3 cohort studies. The participants with gallstone disease had a 38% increase in the risk of IBD (HR 1.38, 95% confidence intervals [CI] 1.21-1.59), 68% increase in Crohn's disease (HR 1.68, 95% CI 1.38-2.06), and 24% increase in ulcerative colitis (HR 1.24, 95% CI 1.03-1.49). In Chinese IBD Etiology Study, we found even larger magnitude of effects between gallstone diseases and IBD risk (IBD: OR 3.03, 95% CI 2.32-3.97; Crohn's disease: OR 5.31; 95% CI 3.71-7.60; ulcerative colitis: OR 1.49; 95% CI 1.07-2.06). There were no major differences in the estimated associations between the presence of unremoved gallstones and prior cholecystectomy with IBD risk.
Discussion: Gallstone disease was linked to an increased risk of IBD and its subtypes, independent of traditional risk factors. Further research is needed to confirm these associations and clarify the underlying biological mechanisms.
Trial registration: ClinicalTrials.gov NCT05882006.
Copyright © 2024 by The American College of Gastroenterology.
References
-
- Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers 2016;2:16024.
-
- Gurusamy KS, Davidson BR. Gallstones. BMJ 2014;348:g2669.
-
- Grigor'eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms 2020;8(6):835.
-
- Ramírez-Pérez O, Cruz-Ramón V, Chinchilla-López P, et al. The role of the gut microbiota in bile acid metabolism. Ann Hepatol 2017;16(Suppl. 1: s3-105.):s15–20.
-
- Rio-Tinto R, Canena J. Endoscopic treatment of post-cholecystectomy biliary leaks. GE Port J Gastroenterol 2021;28(4):265–73.
MeSH terms
Associated data
Grants and funding
- 23JRRA0956/Natural Science Foundation of Gansu Province
- 82204123/National Natural Science Foundation of China
- lzuyxcx-2022-157/Medical Innovation and Development Project of Lanzhou University
- 392012/The Startup Fund for the 100 Top Talents Program, SYSU
- ZSQYRSSFAR0004/Research Supporting Start-up Fund for Associate researcher, of SAHSYSU
LinkOut - more resources
Full Text Sources
Medical